The Story of How Horizon Pharma Creatively Scaled

The Story of How Horizon Pharma Creatively Scaled

In the world of finance and stocks, there are times when “the stars line up” to create an especially interesting story. Such was the case when the announcement was made in March that Chicago-area Horizon Pharma Inc. was joining forces with privately held Vidara Therapeutics (a company which is listed as being headquartered in Roswell, → Read More

Investing Like Iron Man

Investing Like Iron Man

If you are familiar with comic book heroes who have graduated to full-length Hollywood feature films, then you know who “Iron Man” is. You also likely know that Robert Downey, Jr. is the actor who portrays Iron Man, as well as (obviously) the man in the film who built and operates the metal robotic suit/armor → Read More

How Should You Trade Tesla?

How Should You Trade Tesla?

Those accustomed to reading these articles are well aware of my consistent warning regarding the importance of Risk Management.  I suspect that, within a classroom setting, we would all agree that we must each be alert at all times to trades that bear the potential of losing more money than we want to lose on → Read More

Should You Invest In An Irish ETF? (Part I)

Should You Invest In An Irish ETF? (Part I)

With the S&P 500 Index up about 25% over the prior twelve-month period, a number of investors are searching for sensible ways to diversify, without entering new positions in an over-baked “high flier” (eg. Tesla (TSLA)) or one of the more unfamiliar markets (such as some of the “Frontier Markets”: Qatar, Bangladesh, Bahrain, Oman, Tunisia, → Read More

Can You Name the Top 10 ETFs?

Can You Name the Top 10 ETFs?

Since we just completed the third quarter of 2013, it could be telling to review which ETF’s have performed the best thus far year-to-date (as of very early October). Assuming you don’t know which ETFs are in that list, which ones would you guess are included in the list? Emerging markets (including the biggest, China) → Read More

Deal of a Lifetime Or Dangerously Overvalued?

Deal of a Lifetime Or Dangerously Overvalued?

Consider this (true) story about a publically traded company: 1)    EXPERIENCED LEADERSHIP: Entrepreneurial executives with established track records from prior companies are in charge of the company. 2)    ACCESS TO CAPITAL: Multiple deep pocket partners provide more than adequate financing for future growth, and new partners are waiting on the sidelines to “jump in”. 3)    → Read More

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.